Trial Profile
A Pilot Study of Stable Kidney Transplant Recipients Taking Tacrolimus With CNS Symptoms Switched to Envarsus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 10 May 2022 Status changed from active, no longer recruiting to completed.
- 13 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Mar 2020.
- 13 Jan 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Feb 2020.